Canada’s Federal Court ruled recently that the country’s Patented Medicine Prices Review Board — a federal tribunal that regulates pricing on branded medicines — could not extend price-control measures to cover generic drug companies, according to published reports.
As patients across North America continue to turn to their neighborhood pharmacy for vaccinations, state and provincial governments in the United States and Canada are widening the range of immunizations that can be administered by a pharmacist.
A survey co-released on Wednesday by the Generic Pharmaceutical Association and the National Coalition on Healthcare reveals that the healthcare providers patients rely on most to explain safety information about their prescription drugs have serious concerns about a proposed FDA rule on generic drug labeling.
A survey co-released Wednesday by the Generic Pharmaceutical Association and the National Coalition on Healthcare reveals that 8-in-10 healthcare providers have serious concerns about a proposed Food and Drug Administration rule on generic drug labeling.
Walgreens and Arizona Priority Care have announced a clinical care collaboration agreement to provide coordinated, expanded services for AzPC Medicare Advantage and ACO members through select Walgreens pharmacies and Healthcare Clinics.
The Hamacher Resource Group has announced that Dave Wendland, VP and member of the owners group at Hamacher Resource Group, will be speaking to members of the American Society for Automation in Pharmacy June 27 at their 2014 Midyear conference in Palm Beach, Fla., and on July 21, will speak to independent pharmacists attending McKesson’s IdeaShare conference in Orlando, Fla.
Allergan issued a statement Monday, reiterating the company's concern for what it calls Valeant Pharmaceuticals’ “unsustainable business model, which relies on serial acquisitions and cost reductions, as opposed to top-line revenue growth and operational excellence,” the company stated.
New approaches to treating cancer are creating big growth opportunities for the pharmaceutical industry, Moody's Investors Service stated in a report released Thursday titled "Cancer Breakthroughs Bring New Options for Patients and Revenue Streams to Big Pharma."
Teva Pharmaceutical Industries on Thursday announced that the U.S. Court of Appeals for the Federal Circuit upheld a ruling by the U.S. District Court for the District of Delaware finding Bristol-Myers Squibb's entecavir compound claim of U.S. Patent No. 5,206,244 invalid.
Auxilium Pharmaceuticals, a specialty biopharmaceutical company, on Wednesday announced that it has partnered with Prasco to debut the authorized generic form of Testim gel, which is used to treat adult males with low or no testosterone.
Valeant Pharmaceuticals International announced that its subsidiary, Valeant Pharmaceuticals North America, received approval from the Food and Drug Administration for its new drug application for Jublia (efinaconazole 10% topical solution). The drug is the first topical triazole approved for the treatment of onychomycosis of the toenails, the company said.
ThoughtSpot, an annual conference and tradeshow hosted by Good Neighbor Pharmacy on behalf of AmerisourceBergen will take place in the MGM Grand Hotel in Las Vegas on Aug. 1 and 2, GNP announced Thursday.
The House Energy and Commerce Committee on Tuesday advanced bipartisan legislation sponsored by full committee vice chair Marsha Blackburn to address the nation’s growing prescription drug abuse epidemic.
Meals to Heal on Thursday announced that it is working with Walgreens to provide Meals to Heal services to cancer patients and others with chronic conditions in accessing customized nutritional meals and nutrition support services.
A study published Wednesday on JAMA's website found that diabetes patients taking metformin had a higher risk of all-cause death when insulin was added to their treatment as compared to when sulfonylureas were added to treatment.
Mylan on Wednesday announced the launch of risedronate sodium tablets USP, 150 mg. The drug is the generic version of Actonel tablets from Warner Chilcott and is used for the treatment of osteoporosis in post-menopausal women, according to the company.